Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study
Acta Neurologica Scandinavica · 2022-08 · 146 (2) · 167-176
DOI: 10.1111/ane.13648 ↗At a glance
Beobachtungsstudie in Acta Neurologica Scandinavica, published online on 2022-05-24. Written by Alfonso Fasano and 9 co-authors. Institution: Edmond J Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canad…. Major MEDLINE topics: Parkinson Disease. Cited 13 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: AbbVie.
Abstract (original language)
OBJECTIVES: In the absence of widely accepted criteria, determining when a patient with Parkinson's disease (PD) may benefit from more advanced treatments such as device-aided therapy (DAT) so far remains a matter of physician judgment. This analysis investigates how classification of PD varies across countries relative to measures of disease severity. MATERIALS AND METHODS: The OBSERVational, cross-sEctional PD (OBSERVE-PD) study included consecutive patients with PD at centers that offer DATs in 18 countries. In this subgroup analysis, we explore intercountry differences in identification of advanced versus non-advanced PD based on physician's clinical judgment, symptoms assessed using Delphi consensus criteria, use of DAT, motor and non-motor symptoms, and caregiver support. Demographic and clinical characteristics were obtained through review of medical records. RESULTS: Overall, 1342 of 2615 patients (51.3%) were assessed by physicians as having advanced PD. The proportion of patients in different countries identified as having advanced PD (24.4-82.2%) varied. In 15 of 18 countries, a greater proportion of patients with advanced PD, according to select Delphi criteria, were identified by physicians as having advanced PD than with non-advanced PD. There was a wide variability across countries in the proportion of patients with no dyskinesia, disabling dyskinesia, dyskinesia pain, and non-motor symptoms who were identified by physicians as having advanced versus non-advanced PD. CONCLUSIONS: The proportion of patients identified with advanced PD symptoms varies widely across countries, despite differences on the patients' profiles, indicating a need for objective diagnostic criteria to help identify patients who may benefit from DAT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Edmond J Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
- Division of Neurology, University of Toronto, Toronto, ON, Canada.
- Krembil Research Institute, Toronto, ON, Canada.
- Movement Disorders Unit, Westmead Hospital, Westmead, NSW, Australia.
- Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
- Medical University Innsbruck, Innsbruck, Austria.
Funding
- AbbVie
Cite
APA
Fasano, A., Fung, V. S. C., Seppi, K., Pirtosek, Z., Takáts, A., Alobaidi, A., Onuk, K., Bergmann, L., Parra, J. C., & Elibol, B. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica, 146(2), 167-176. https://doi.org/10.1111/ane.13648
Vancouver
Fasano A, Fung VSC, Seppi K, Pirtosek Z, Takáts A, Alobaidi A, et al. Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 2022;146(2):167-176. doi:10.1111/ane.13648
BibTeX
@article{Fasano2022,
author = {Fasano, Alfonso and Fung, Victor S C and Seppi, Klaus and Pirtosek, Zvezdan and Takáts, Annamária and Alobaidi, Ali and Onuk, Koray and Bergmann, Lars and Parra, Juan Carlos and Elibol, Bulent},
title = {Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study},
journal = {Acta Neurologica Scandinavica},
year = {2022},
volume = {146},
number = {2},
pages = {167--176},
doi = {10.1111/ane.13648}
}
EUVIMED